Skip to main content
. 2009 Dec;11(12):1383–1389. doi: 10.1593/neo.91018

Table 5.

Distribution of Clones According to the Seroreactivity Frequency Determined for Glioma and for Healthy Controls (First and Second Column).

Frequency Range Glioma Healthy Glioma (Twice)



No. All Clones No. In-frame Clones No. All Clones No. In-frame Clones No. All Clones No. In-frame Clones
0% 51 17 176 62
0–10% 536 176 552 169 152 91
10–20% 444 117 305 78 109 49
20–30% 187 40 163 36 34 5
30–40% 100 20 93 22 7 2
40–50% 54 14 55 8 3 0
50–60% 22 3 30 9 2 0
60–70% 16 4 27 5 1 0
70–80% 4 0 11 2 0 0
80–90% 3 0 4 0 0 0
90–100% 0 0 1 0 0 0

The third column lists clones that react at least twice as often with glioma sera than with healthy control sera. Number of all clones and number of in-frame clones are given for each frequency interval.